Related Experiment Video
Updated: Aug 20, 2026

Bead Aggregation Assays for the Characterization of Putative Cell Adhesion Molecules
Published on: October 17, 2014
VE-cadherin links tRNA synthetase cytokine to anti-angiogenic function
Eleni Tzima1, John S Reader, Mohamad Irani-Tehrani
1Skaggs Institute for Chemical Biology, Department of Chemistry and Molecular Biology, The Scripps Research Institute, La Jolla, California 92037, USA. etzima@scripps.edu
Abstract:
A natural fragment of an enzyme that catalyzes the first step of protein synthesis-human tryptophanyl-tRNA synthetase (T2-TrpRS) has potent anti-angiogenic activity. A cellular receptor through which T2-TrpRS exerts its anti-angiogenic activity has not previously been identified. Here T2-TrpRS was shown to bind at intercellular junctions of endothelial cells (ECs). Using genetic knock-outs, binding was established to depend on VE-cadherin, a calcium-dependent adhesion molecule, which is selectively expressed in ECs, concentrated at adherens junctions, and is essential for normal vascular development. In contrast, T2-TrpRS binding to EC junctions was not dependent on platelet endothelial cell adhesion molecule type-1, another adhesion molecule found at EC junctions. Pull-down assays confirmed direct complex formation between T2-TrpRS and VE-cadherin. Binding of T2-TrpRS inhibited VEGF-induced ERK activation and EC migration. Thus, a VE-cadherin-dependent pathway is proposed to link T2-TrpRS to inhibition of new blood vessel formation.
Insights
A fragment of human tryptophanyl-tRNA synthetase (T2-TrpRS) inhibits new blood vessel formation by binding to VE-cadherin on endothelial cells. This interaction blocks key signaling pathways, revealing a novel anti-angiogenic mechanism.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- The enzyme fragment human tryptophanyl-tRNA synthetase (T2-TrpRS) exhibits anti-angiogenic properties.
- The specific cellular receptor mediating T2-TrpRS anti-angiogenic activity was previously unknown.
Purpose of the Study:
- To identify the cellular receptor for T2-TrpRS.
- To elucidate the mechanism by which T2-TrpRS inhibits angiogenesis.
Main Methods:
- Investigated T2-TrpRS binding to endothelial cells (ECs).
- Utilized genetic knock-outs to determine the role of VE-cadherin and PECAM-1 in T2-TrpRS binding.
- Performed pull-down assays to confirm direct complex formation.
- Assessed the impact of T2-TrpRS binding on VEGF-induced ERK activation and EC migration.
Main Results:
- T2-TrpRS binds to intercellular junctions of ECs.
- Binding is dependent on VE-cadherin, an EC-specific adhesion molecule, but not PECAM-1.
- Direct complex formation between T2-TrpRS and VE-cadherin was confirmed.
- T2-TrpRS binding inhibited VEGF-induced ERK activation and EC migration.
Conclusions:
- VE-cadherin serves as the cellular receptor for T2-TrpRS on ECs.
- A VE-cadherin-dependent pathway links T2-TrpRS to the inhibition of angiogenesis.
- T2-TrpRS represents a novel therapeutic target for anti-angiogenic strategies.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Structure of Cadherins
Mechanism of Angiogenesis
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
